Twist Bioscience (TWST) Cash & Current Investments (2018 - 2026)

Twist Bioscience (TWST) has reported Cash & Current Investments for 9 consecutive years, with $171.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Current Investments fell 33.22% year-over-year to $171.7 million; the TTM figure through Mar 2026 stood at $171.7 million (down 33.22% YoY), while the FY2025 annual figure was $232.4 million, down 15.91% from the prior year.
• Cash & Current Investments fell to $171.7 million in Q1 2026 per TWST's latest filing, from $197.9 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $573.9 million in Q1 2022 and bottomed at $171.7 million in Q1 2026.
• Historically, Cash & Current Investments has averaged $334.0 million across 5 years, with a median of $293.3 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Current Investments soared 45.34% — and 2023, when it tumbled 33.38%.
• Twist Bioscience's Cash & Current Investments stood at $438.7 million in 2022, then decreased by 29.08% to $311.1 million in 2023, then retreated by 12.96% to $270.8 million in 2024, then slipped by 26.91% to $197.9 million in 2025, then declined by 13.26% to $171.7 million in 2026.
• Business Quant data shows TWST's Cash & Current Investments at $171.7 million in Q1 2026, $197.9 million in Q4 2025, and $232.4 million in Q3 2025.